risperidone has been researched along with galantamine in 31 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 14 (45.16) | 29.6817 |
| 2010's | 14 (45.16) | 24.3611 |
| 2020's | 3 (9.68) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Allen, TB; McEvoy, JP | 1 |
| Huang, F; Janssens, L; Lasseter, KC; Lau, H; Verhaeghe, T; Zhao, Q | 1 |
| Arya, P; Butler, R; Warner, J | 1 |
| Bennouna, M; Defranoux, L; Greene, VB | 1 |
| Hicks, PB; Schubert, MH; Young, KA | 1 |
| Duaso, E; Formiga, F; Fort, I; Pérez-Castejón, JM; Riu, S; Ruiz, D | 1 |
| Furukawa, H; Nabeshima, T; Nitta, A; Noda, Y; Wang, D; Zhou, Y | 2 |
| Ago, Y; Baba, A; Hashimoto, H; Kawasaki, T; Koda, K; Matsuda, T | 1 |
| Bogetto, F; Marino, F; Montemagni, C; Perrone, D; Rocca, P | 1 |
| Federley, M; Fjällström, AK; Persson, P; Stenqvist, P; Wadenberg, ML | 1 |
| Khan, A; Lindenmayer, JP | 1 |
| Eriksdotter, M; Freund-Levi, Y; Jedenius, E; Lärksäter, M; Tysen-Bäckström, AC; Wahlund, LO | 2 |
| Akhondzadeh, S; Farokhnia, M; Ghaleiha, A; Ghyasvand, M; Hajiaghaee, R; Mohammadi, MR; Tabrizi, M; Yadegari, N; Yekehtaz, H | 1 |
| Aarsland, D; Auestad, B; Bloniecki, V; Freund-Levi, Y; Lärksäter, M; Tysen Bäckström, AC | 1 |
| Bogaisky, M | 1 |
| Blazer, D; Reifler, BV | 1 |
| Aarsland, D; Blennow, K; Bloniecki, V; Cummings, J; Falahati, F; Freund-Levi, Y; Winblad, B | 1 |
| Agrawal, M; Alexander, A; Antimisiaris, SG; Chougule, MB; Saraf, S; Shoyele, SA | 1 |
| Aarsland, D; Andersson, T; Berglund, A; Cummings, J; Freund-Levi, Y; Holmgren, S | 1 |
| Cox, GR; Haslam, R; Ure, A; Williams, K | 1 |
| Cai, WJ; Chen, KL; Chen, SD; Dong, Q; Feng, L; Giovane, CD; Huang, SY; Huang, YY; Kuo, K; Li, CB; Liu, CY; Shen, XN; Suckling, J; Teng, T; Wang, RZ; Yu, JT; Zhang, C; Zhao, QH; Zhou, XY | 1 |
5 review(s) available for risperidone and galantamine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Dementia.
Topics: Alzheimer Disease; Antipsychotic Agents; Benzodiazepines; Cognition; Dementia; Donepezil; Galantamine; Ginkgo biloba; Haloperidol; Humans; Indans; Memantine; Olanzapine; Phenylcarbamates; Physostigmine; Phytotherapy; Piperidines; Risperidone; Rivastigmine; Selegiline; Tacrine; Vitamin E | 2004 |
Nose-to-brain drug delivery: An update on clinical challenges and progress towards approval of anti-Alzheimer drugs.
Topics: Administration, Intranasal; Alzheimer Disease; Animals; Biological Availability; Blood-Brain Barrier; Brain; Deferoxamine; Donepezil; Drug Carriers; Drug Liberation; Galantamine; Humans; Mucociliary Clearance; Nanoparticles; Nasal Mucosa; Nose; Olfactory Bulb; Risperidone; Tissue Distribution | 2018 |
Acetylcholinesterase inhibitors for autistic spectrum disorders.
Topics: Acetylcholine; Adolescent; Autism Spectrum Disorder; Child; Child, Preschool; Cholinesterase Inhibitors; Donepezil; Galantamine; Humans; Risperidone; Rivastigmine | 2023 |
Pharmacological treatment of neuropsychiatric symptoms of dementia: a network meta-analysis.
Topics: Aged; Databases, Factual; Dementia; Galantamine; Humans; Network Meta-Analysis; Randomized Controlled Trials as Topic; Risperidone | 2023 |
7 trial(s) available for risperidone and galantamine
| Article | Year |
|---|---|
Pharmacokinetic and safety assessments of galantamine and risperidone after the two drugs are administered alone and together.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Area Under Curve; Biological Availability; Cholinesterase Inhibitors; Cross-Over Studies; Dose-Response Relationship, Drug; Drug Interactions; Female; Galantamine; Gas Chromatography-Mass Spectrometry; Humans; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Pyrimidines; Risperidone; Time Factors | 2002 |
Galantamine improves cognition in schizophrenic patients stabilized on risperidone.
Topics: Adult; Antipsychotic Agents; Cholinesterase Inhibitors; Cognition; Double-Blind Method; Female; Galantamine; Humans; Male; Middle Aged; Neuropsychological Tests; Psychotic Disorders; Risperidone; Schizophrenia | 2006 |
Galantamine augmentation of long-acting injectable risperidone for cognitive impairments in chronic schizophrenia.
Topics: Adult; Antipsychotic Agents; Chronic Disease; Cognition Disorders; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Galantamine; Humans; Injections, Intramuscular; Male; Middle Aged; Neuropsychological Tests; Nootropic Agents; Psychiatric Status Rating Scales; Psychometrics; Risperidone; Schizophrenia | 2011 |
Galantamine versus risperidone treatment of neuropsychiatric symptoms in patients with probable dementia: an open randomized trial.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Cholinesterase Inhibitors; Dementia; Female; Galantamine; Humans; Irritable Mood; Male; Neuropsychological Tests; Psychomotor Agitation; Risperidone; Treatment Outcome | 2014 |
Galantamine efficacy and tolerability as an augmentative therapy in autistic children: A randomized, double-blind, placebo-controlled trial.
Topics: Antipsychotic Agents; Autistic Disorder; Checklist; Child; Child Behavior; Child, Preschool; Cholinesterase Inhibitors; Double-Blind Method; Drug Therapy, Combination; Female; Galantamine; Humans; Iran; Male; Risperidone; Surveys and Questionnaires; Time Factors; Treatment Outcome | 2014 |
Galantamine versus risperidone for agitation in people with dementia: a randomized, twelve-week, single-center study.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antipsychotic Agents; Dementia; Dementia, Vascular; Female; Galantamine; Humans; Male; Nootropic Agents; Psychomotor Agitation; Risperidone; Treatment Outcome | 2014 |
Effects of Risperidone and Galantamine Treatment on Alzheimer's Disease Biomarker Levels in Cerebrospinal Fluid.
Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Cholinesterase Inhibitors; Follow-Up Studies; Galantamine; Humans; Peptide Fragments; Phosphorylation; Psychotropic Drugs; Risperidone; tau Proteins; Treatment Outcome | 2017 |
19 other study(ies) available for risperidone and galantamine
| Article | Year |
|---|---|
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Galantamine for treatment-resistant schizophrenia.
Topics: Adult; Agranulocytosis; Antipsychotic Agents; Cholinesterase Inhibitors; Clozapine; Drug Therapy, Combination; Galantamine; Humans; Male; Middle Aged; Parasympathomimetics; Risperidone; Schizophrenia | 2002 |
Adjuvant galantamine to risperidone improves negative and cognitive symptoms in a patient presenting with schizophrenialike psychosis after traumatic brain injury.
Topics: Adult; Antipsychotic Agents; Brain Hemorrhage, Traumatic; Cholinesterase Inhibitors; Cognition Disorders; Female; Galantamine; Humans; Psychiatric Status Rating Scales; Psychotic Disorders; Risperidone; Schizophrenic Psychology | 2005 |
[Risperidone and cerebrovascular adverse effects in elderly patients with dementia].
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Cerebrovascular Disorders; Cholinesterase Inhibitors; Dementia, Vascular; Donepezil; Female; Galantamine; Humans; Indans; Male; Piperidines; Risperidone | 2006 |
Synergistic effect of galantamine with risperidone on impairment of social interaction in phencyclidine-treated mice as a schizophrenic animal model.
Topics: Analysis of Variance; Animals; Antipsychotic Agents; Behavior, Animal; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Drug Synergism; Galantamine; Interpersonal Relations; Male; Mice; Mice, Inbred ICR; Microdialysis; Nootropic Agents; Phencyclidine; Prefrontal Cortex; Risperidone; Schizophrenia | 2007 |
Synergistic effect of combined treatment with risperidone and galantamine on phencyclidine-induced impairment of latent visuospatial learning and memory: Role of nAChR activation-dependent increase of dopamine D1 receptor-mediated neurotransmission.
Topics: Analysis of Variance; Animals; Antipsychotic Agents; Behavior, Animal; Dose-Response Relationship, Drug; Drug Synergism; Excitatory Amino Acid Antagonists; Galantamine; Learning Disabilities; Male; Memory Disorders; Mice; Mice, Inbred ICR; Microdialysis; Nootropic Agents; Phencyclidine; Reaction Time; Receptors, Dopamine D1; Receptors, Nicotinic; Risperidone; Space Perception | 2007 |
Galantamine and donepezil differently affect isolation rearing-induced deficits of prepulse inhibition in mice.
Topics: Aconitine; Acoustic Stimulation; alpha7 Nicotinic Acetylcholine Receptor; Analysis of Variance; Animals; Animals, Outbred Strains; Apomorphine; Behavior, Animal; Cholinesterase Inhibitors; Dizocilpine Maleate; Donepezil; Dose-Response Relationship, Drug; Galantamine; Indans; Male; Mecamylamine; Mice; Neural Inhibition; Nicotinic Antagonists; Piperidines; Receptors, Nicotinic; Reflex, Startle; Risperidone; Social Isolation | 2008 |
Risperidone, olanzapine and quetiapine in the treatment of behavioral and psychological symptoms in patients with Alzheimer's disease: preliminary findings from a naturalistic, retrospective study.
Topics: Activities of Daily Living; Aged; Alzheimer Disease; Antipsychotic Agents; Behavior; Benzodiazepines; Cognition; Data Interpretation, Statistical; Dibenzothiazepines; Donepezil; Endpoint Determination; Female; Galantamine; Humans; Indans; Long-Term Care; Male; Neuropsychological Tests; Nootropic Agents; Olanzapine; Phenylcarbamates; Piperidines; Psychiatric Status Rating Scales; Quetiapine Fumarate; Retrospective Studies; Risperidone; Rivastigmine; Treatment Outcome | 2007 |
Drug-induced sialorrhoea and excessive saliva accumulation.
Topics: Antipsychotic Agents; Benzodiazepines; Cholinesterase Inhibitors; Clozapine; Deglutition Disorders; Donepezil; Galantamine; Humans; Hypnotics and Sedatives; Indans; Phenylcarbamates; Pilocarpine; Piperidines; Quality of Life; Risperidone; Rivastigmine; Sialorrhea | 2009 |
Effects of adjunct galantamine to risperidone, or haloperidol, in animal models of antipsychotic activity and extrapyramidal side-effect liability: involvement of the cholinergic muscarinic receptor.
Topics: Animals; Antipsychotic Agents; Avoidance Learning; Behavior, Animal; Catalepsy; Cholinergic Antagonists; Cholinesterase Inhibitors; Disease Models, Animal; Extrapyramidal Tracts; Galantamine; Haloperidol; Male; Mecamylamine; Motor Activity; Nicotinic Antagonists; Rats; Rats, Wistar; Receptors, Muscarinic; Risperidone; Schizophrenia; Scopolamine | 2011 |
Response to Bogaiksy's letter to the editor.
Topics: Antipsychotic Agents; Cholinesterase Inhibitors; Dementia; Female; Galantamine; Humans; Irritable Mood; Male; Psychomotor Agitation; Risperidone | 2014 |
Galantamine versus risperidone treatment of neuropsychiatric symptoms in patients with probable dementia: an open randomized trial.
Topics: Antipsychotic Agents; Cholinesterase Inhibitors; Dementia; Female; Galantamine; Humans; Irritable Mood; Male; Psychomotor Agitation; Risperidone | 2014 |
An unsubstantiated conclusion.
Topics: Antipsychotic Agents; Cholinesterase Inhibitors; Dementia; Female; Galantamine; Humans; Irritable Mood; Male; Psychomotor Agitation; Risperidone | 2015 |
Neuropsychiatric Symptoms in Dementia: Considering a Clinical Role for Electroencephalography.
Topics: Alzheimer Disease; Dementia; Electroencephalography; Galantamine; Humans; Neuropsychological Tests; Risperidone | 2022 |